)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Bio-Techne
Bio-Techne (TECH) investor relations material
Bio-Techne Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary9 Jul, 2026
Executive summary
Merger agreement signed for acquisition by Merck KGaA, Darmstadt, Germany, with closing expected by late 2026 or early 2027, pending regulatory and shareholder approvals.
Both companies will operate independently until closing, with a focus on business continuity and compliance with legal requirements.
Integration aims to leverage complementary strengths, retain critical talent, and expand global reach and capabilities.
Forward-looking statements highlight risks such as integration challenges, regulatory approvals, and potential business disruptions.
Voting matters and shareholder proposals
Shareholder approval is required for the transaction to proceed.
Proxy materials will be filed with the SEC and made available to shareholders for voting.
Board of directors and corporate governance
Information about directors and executive officers, including compensation and governance, is referenced in prior proxy statements and SEC filings.
Any changes in holdings by directors or officers will be disclosed in future SEC filings.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bio-Techne
- Strong innovation and market recovery position the business for accelerated growth by late 2026.TECH
53rd Annual Nasdaq Investor Conference9 Jul 2026 - Q2 organic revenue rose 9% to $297M, with strong segment growth and margin expansion.TECHQ2 20258 Jul 2026
- Momentum in core markets and innovation signal a return to growth and margin expansion.TECHStifel 2025 Healthcare Conference8 Jul 2026
- Definitive acquisition agreement reached, with $73.00 per share cash offer pending approvals.TECHProxy filing25 Jun 2026
- Core products and growth verticals outperformed amid weak biotech, with strong pharma and China growth.TECHBank of America Global Healthcare Conference 202612 May 2026
- Q3 FY2026 revenue dipped 2% but margins and earnings improved on cost controls and growth areas.TECHQ3 202612 May 2026
- Growth led by pharma and China, with biotech and academic recovery fueling optimism.TECHLeerink Global Healthcare Conference 202610 Mar 2026
- Strong growth in pharma, margin expansion, and M&A drive confidence for fiscal 2026.TECHTD Cowen 46th Annual Health Care Conference3 Mar 2026
- Flat revenue, higher margins, and strong pharma/Asia growth offset mixed segment results.TECHQ2 20264 Feb 2026
Next Bio-Techne earnings date
Q4 20265 Aug, 2026
Bio-Techne
Next Bio-Techne earnings date
Q4 20265 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage